P2.01-14 Phase 3 Trial of Sitravatinib Plus Nivolumab vs Docetaxel for Treatment of NSCLC After Platinum-Based Chemoimmunotherapy

E. Nidhiry,T. Mekhail, E. Thara,M. Nagasaka, C. Chen, B.G. Gopurala, N. Campbell,K. Eaton, Y. Homsi, R. Yanagihara, R. Vaddepally,X. Yan,V. Tassell,S. Neuteboom,R. Chao, R. Keresztes

JOURNAL OF THORACIC ONCOLOGY(2019)

引用 0|浏览32
暂无评分
关键词
Immunology,advanced NSCLC
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要